RXST Investors Have Opportunity to Lead RxSight, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Core Viewpoint - A class action lawsuit has been filed against RxSight, Inc. for alleged violations of securities laws, claiming the company made false and misleading statements regarding its financial performance and customer demand [1][4]. Group 1: Lawsuit Details - The lawsuit pertains to securities purchased between November 7, 2024, and July 8, 2025, during which investors are encouraged to participate before September 22, 2025 [2]. - The Schall Law Firm is representing investors and has not yet certified the class, meaning potential participants are not yet represented by an attorney [3]. Group 2: Allegations Against RxSight - The complaint alleges that RxSight faced "adoption challenges" leading to declining sales and utilization rates, and that the company overstated customer demand for its products [4]. - It is claimed that RxSight is unlikely to meet its financial guidance for fiscal year 2025, and that its public statements were materially misleading throughout the class period [4].